Copyright © 2002 by the European Society of Cardiology.
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation
a Department of Cardiology and Arrhythmologic Center, Ospedali Riuniti, Lavagna, Italy
b Department of Interventional Cardiology and Arrhythmologic Center, Ospedale S Maria Nuova, Reggio Emilia, Italy
c Department of Cardiology, Istituto Humanitas, Milano, Italy
d Department of Cardiology, Ospedale Cisanello, Pisa, Italy
e Department of Cardiology, Ospedale S. Anna, Como, Italy
f Department of Cardiology, Ospedale S. Bortolo, Vicenza, Italy
g Department of Cardiology, Ospedale Civile, Cento, Italy
h Department of Cardiology, Ospedale S Croce, Cuneo, Italy
i Department of Cardiology, Ospedale S Gerardo, Monza, Italy
j Department of Cardiology, Ospedale Civile P. Cosma, Camposampiero, Italy
revised August 7, 2001; accepted August 15, 2001
Abstract
Aims Permanent atrial fibrillation develops in many patients after ablation and pacing therapy. We compared a strategy that initially allowed patients to remain in atrial fibrillation with a strategy that initially attempted to restore and maintain sinus rhythm.
Methods and Results In this multicentre randomized controlled trial, 68 patients affected by severely symptomatic paroxysmal atrial fibrillation were assigned, after successful atrioventricular junction ablation and pacing treatment, to antiarrhythmic drug therapy with amiodarone, propafenone, flecainide or sotalol and were compared with 69 patients assigned, after successful AV junction ablation and pacing treatment, to no antiarrhythmic drug therapy. The patients were followed-up for 12 to 24 months (mean 16±4). The drug arm patients had a 57% reduction in the risk of developing permanent atrial fibrillation (21% vs 37%,P =0·02). Evaluation after 12 months revealed similar quality of life scores and echocardiographic parameters in the two groups, but the drug arm patients had more episodes of heart failure and hospitalizations (P=0·05). The outcome was similar between the 40 patients who developed permanent atrial fibrillation and the 97 who did not.
Conclusion Conventional antiarrhythmic therapy reduces the risk of development of permanent atrial fibrillation after ablation and pacing therapy. The present data do not support the concept that the development of permanent atrial fibrillation is related to an adverse outcome when a perfect control of heart rate is obtained by ablation and pacing. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved
Key Words: Catheter ablation, atrial fibrillation, pacemakers, antiarrhythmia agents, atrioventricular node
f1 Correspondence: Michele Brignole, Department of Cardiology and Arrhythmologic Centre, Ospedali Riuniti, Via don Bobbio, 16032 Lavagna, Italy.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Roy, M. Talajic, S. Nattel, D. G. Wyse, P. Dorian, K. L. Lee, M. G. Bourassa, J. M. O. Arnold, A. E. Buxton, A. J. Camm, et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure N. Engl. J. Med., June 19, 2008; 358(25): 2667 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Betts Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients Europace, April 1, 2008; 10(4): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace, November 1, 2007; 9(11): 1006 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brignole A novel use of cardiac pacing to improve cardiac function, quality of life and (hopefully) survival in patients with heart failure and permanent atrial fibrillation Eur. Heart J., November 2, 2002; 23(22): 1732 - 1736. [Full Text] [PDF] |
||||
![]() |
S.R. Raj and D.G. Wyse Rhythm control for paroxysmal atrial fibrillation after AV junction ablation: is it worth the effort? Eur. Heart J., June 1, 2002; 23(11): 845 - 848. [Full Text] [PDF] |
||||


